News and Press Releases

Oxeltis and academic partners receive grant funding worth nearly €800,000 to develop antiviral for Bunyaviricetes 

France’s National Research Agency (ANR) and Defense Innovation Agency (AID) will finance BUNYANTIVIR project to introduce novel therapeutic approach for Bunyaviricetes class of human pathogenic viruses found in tropical and...

Category:
Posted: June 25, 2025

Cap Gamma, 1682 rue de la Valsière, BP 7247 34086 Montpellier Cedex 4 – France

Advarra Integrates Study Startup and IRB Technologies, Enabling Unprecedented Visibility into Clinical Trial Site Activation

New release of Advarra’s Study Collaboration solution provides sponsors and CROs a single view into the progress of site activation milestones and IRB review status across sites 17 April 2025...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 17, 2025

6100 Merriweather Dr., Suite 600 Columbia, MD 21044

Pistoia Alliance Launches Initiative to Assess Sustainability of Digital vs. Traditional Clinical Trial Approaches

New initiative will collect pharma and CRO data to refine industry carbon measurement of technologies like remote monitoring and eConsent, informing more sustainable trial design 20 March 2025, Massachusetts, US...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 20, 2025

401 Edgewater Pl, Wakefield, Massachusetts, US

Innovaderm Research Rebrands as Indero, a dual-focus CRO 

7 March 2025 -- Quebec, Canada -- Innovaderm, a leading clinical research organization (CRO), is excited to reveal a major rebranding to Indero, with immediate effect. The new brand identity...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 7, 2025

3530 Saint-Laurent boulevard, Suite 300 Montreal, QC, H2X 2V1, Canada

Schrödinger Selects Sapio Sciences to Enhance In Silico Drug Discovery From Plasmid to Structure

Configurable informatics platform improves lab efficiency, data tracking, and resource management from plasmid to structure 28 January 2025 – Baltimore, MD, US – Sapio Sciences, the science-aware™ lab informatics platform,...

Category: BioManufacturing, Drug Discovery
Posted: January 28, 2025

400 East Pratt Street #800 Baltimore, MD 21202

Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials

9 January 2025 -- Cambridge, UK and Montreal, Canada -- Biofidelity, a leader in innovative genomic solutions, and CellCarta, the global contract research organization (CRO) partner of choice for biopharmaceutical...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: January 9, 2025

5151 McCrimmon Parkway, Suite 230 Morrisville, NC 27560

Tracey Marantal Joins Worldwide Clinical Trials as President, Oncology Business Unit

Proven clinical operations leader joins global CRO to lead high-performing therapeutic team and drive strategy for growing oncology portfolio 24 September 2024 -- North Carolina, US -- Tracey Marantal has...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 24, 2024

600 Park Offices Drive Suite 200 Research Triangle Park, NC 27709 USA

Veridix AI, part of Emmes Group, Announces New Protocol Digitization Capabilities

Protocol digitization extracts structured data elements from unstructured text Automates database study builds, reducing build timelines by up to 30% Deployed within 40 study builds across Emmes CRO’s portfolio of...

Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: August 14, 2024

401 N. Washington Street Suites 700 Rockville, MARYLAND 20850

Phase 2b Influenza Field Study Contract

hVIVO to enrol up to 1,000 healthy volunteers as part of a multicentre field study testing an influenza drug candidate, with hVIVO selected as the sole UK clinical site Largest...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: July 2, 2024

40 Bank Street, Floor 24, London, E14 5NR

Mage Biologics announces first subject dosed in a phase 1 trial with MB-001, an orally administered antibody for Inflammatory Bowel Disease

12 June 2024 -- Delaware, US -- Mage Biologics announces it has dosed the first study participant in a first-in-human study of MB-001, a best-in-class orally administered antibody designed for...

Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: June 19, 2024

Baslerstrasse 15 CH-4310 Rheinfelden Switzerland

Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting

PPD clinical research business leads real-world data and technology panel, receives CRO Leadership Award 17 June 2024 -- California, US -- The PPD clinical research business of Thermo Fisher Scientific,...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 17, 2024

168 Third Avenue Waltham, MA 02451

Altasciences Receives 2024 CRO Leadership Award for Capabilities

16 May 2024 -- Laval, Québec, Canada -- Altasciences announced today that it has been recognised for excellence in contract research with a 2024 CRO Leadership Award for Capabilities. This...

Category: BioManufacturing, Clinical Trials, Pharmaceutical
Posted: June 3, 2024

575 Armand-Frappier Blvd. Laval, QC H7V 4B3 Canada

TMC welcomes Joe Lopez as Chief Financial Officer (CFO) to enhance corporate C-level team

3 June 2024 -- Hampshire, UK -- TMC Pharma Services, an established global product development and clinical research organisation (CRO) headquartered in Hampshire, UK, is pleased to announce the appointment...

Category: Clinical Trials, Pharmaceutical
Posted: June 3, 2024

Lodge Farm Barn Elvetham Park Estate, Fleet Road, Hartley Wintney, Hampshire RG27 8AS, UK

New CRO Focused on Cannabis-based Drug Trials Launched

22 May 2024 -- Georgia, US -- Cannovation Clinical Research Partners, a pioneering Cannabis-Based clinical research organisation (CRO) for Drug and Product Development, is proudly announcing its official launch, marking...

Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: May 22, 2024

3300 Hamilton Mill Rd Ste 102 PMB 3024 Buford, GA 30519

First Commercial Cell and Gene Therapy Product Manufactured at Minaris Regenerative Medicine in Allendale, New Jersey, US

With the recent FDA approval of LYFGENIA, developed by bluebird bio, Minaris Regenerative Medicine North America is now supporting a commercial cell and gene therapy (CGT) product The first commercial...

Category: BioManufacturing, Biotechnology
Posted: May 8, 2024

4 Pearl Court, Allendale, New Jersey, 07401